Company news

Codexis, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Codexis to Participate in Enzymatic Synthesis Presentations at RNA Leaders Annual Meeting

August 19, 2024

Codexis Publishes FY2023 Sustainability Disclosures

August 14, 2024

Codexis Reports Second Quarter 2024 Financial Results

August 7, 2024

Codexis to Report Second Quarter 2024 Financial Results on August 8

July 17, 2024

Codexis Finalizes Purchase Agreement with Crosswalk Therapeutics for Gene Therapy Assets

June 30, 2024

Codexis to Participate in TD Cowen 2nd Annual Sustainability Week

May 19, 2024

Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting

May 13, 2024

Codexis Reports First Quarter 2024 Financial Results

May 1, 2024

Codexis to Report First Quarter 2024 Financial Results on May 2

April 17, 2024

Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board

April 10, 2024

Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results

February 27, 2024

Codexis to Participate in TD Cowen 44th Annual Health Care Conference

February 25, 2024

Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche

February 25, 2024

Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board

February 19, 2024

Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28

February 13, 2024

Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key Milestones

February 12, 2024

seqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General Meeting

January 31, 2024

Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108

December 26, 2023

Codexis Announces Achievement of Gram-scale Synthesis with its ECO Synthesis™ Platform

December 12, 2023

Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase

December 12, 2023

Codexis KOL Event Highlights Significant Need for an Enzymatic Route of Synthesis in RNAi Therapeutics Manufacturing

December 10, 2023

Codexis to Host Virtual KOL Event on its ECO Synthesis™ Platform and the Future of RNAi Therapeutics Manufacturing on December 8, 2023

November 27, 2023

Codexis to Participate in 35th Annual Piper Sandler Healthcare Conference

November 13, 2023

Codexis Reports Third Quarter 2023 Financial Results

November 1, 2023

Codexis to Present Update on ECO Synthesis™ Platform at TIDES Europe

October 25, 2023

Codexis to Report Third Quarter 2023 Financial Results on November 2

October 18, 2023

Codexis CEO Stephen Dilly Wins Prestigious 2023 Bloom Burton Award

September 28, 2023

Codexis CEO Stephen Dilly Named as Finalist of 2023 Bloom Burton Award

September 17, 2023

Codexis Announces Agreement for Assignment and Assumption of San Carlos Facility Lease

September 6, 2023

Codexis Reports Second Quarter 2023 Financial Results

August 2, 2023

Codexis Documentary Showcases its Specialized Capabilities Engineering High Performance Enzymes to Enable Delivery of Novel Therapeutics

July 30, 2023

Codexis Announces Enhanced Strategic Focus and Extends Projected Cash Runway to Mid-2026

July 19, 2023

Codexis to Participate in Jefferies Healthcare Conference

May 23, 2023

Codexis Unveils ECO Synthesis™ Platform for Large-Scale RNAi Therapeutics Production at TIDES USA

May 9, 2023

Codexis Reports First Quarter 2023 Financial Results

May 3, 2023

Codexis to Report First Quarter 2023 Financial Results on May 4

April 19, 2023

Codexis Announces RNA Therapeutics Manufacturing Workshop at TIDES USA

April 18, 2023

Codexis Announces Decision of Patrick Yang, PhD, Not to Seek Re-Election to Board of Directors

April 3, 2023

Codexis to Participate in Cowen 43rd Annual Health Care Conference

February 26, 2023

Codexis Reports Fourth Quarter and Fiscal Year 2022 Financial Results

February 22, 2023

Codexis and Nestlé Health Science Announce Interim Results from Phase 1 Clinical Trial of CDX-7108 for Exocrine Pancreatic Insufficiency

February 22, 2023

Codexis Announces Several Key Presentations from its Gene Therapy Programs at 19th Annual WORLDSymposium™

February 21, 2023

Codexis to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 23

February 8, 2023

Codexis Announces Appointment of Sri Ryali as Chief Financial Officer

January 22, 2023

Codexis Announces Appointment of H. Stewart Parker to Board of Directors

December 19, 2022

Codexis Provides Update on Prioritized Corporate Strategy

November 28, 2022

Codexis to Participate in Piper Sandler 34th Annual Healthcare Conference

November 15, 2022

Codexis Reports Third Quarter 2022 Financial Results

November 2, 2022

Codexis Announces Appointment of Margaret Fitzgerald as Chief Legal Officer and General Counsel

October 31, 2022

Codexis to Report Third Quarter 2022 Financial Results on November 3

October 19, 2022

← Newer news releases · Older news releases →

Calls

The 5 newest of 18 calls. Every call is listed under its year.

Decks

The 5 newest of 24 decks. Every deck is listed under its year.